NOVN vs RO: Side-by-Side Comparison
Compare Novartis AG (NOVN) and Roche Holding AG (RO) side by side: market cap CHF 244.54B vs CHF 267.01B, P/E 22.7 vs 20.9. Financials, growth and model signals on Bullrun.
| Metric | NOVN | RO |
|---|---|---|
| Company | Novartis AG | Roche Holding AG |
| Country / Exchange | Switzerland · SW | Switzerland · SW |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Market cap | CHF 244.54B | CHF 267.01B |
| P/E ratio | 22.7 | 20.9 |
| Dividend yield | 2.96% | 2.89% |
| Valuation model | 6.8% undervalued | — |
| Revenue (latest FY) | — | CHF 63.36B |
| Revenue growth YoY | — | +1.5% |
| Net income | — | CHF 12.88B |
| Gross margin | — | 73.7% |
| Diluted EPS | — | 16.04 |